Last reviewed · How we verify
PF-07104091 + PF-07220060 + letrozole dose expansion (pf-07104091-pf-07220060-letrozole-dose-expansion)
PF-07104091 + PF-07220060 + letrozole dose expansion (generic name: pf-07104091-pf-07220060-letrozole-dose-expansion) is a drug developed by Pfizer Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | pf-07104091-pf-07220060-letrozole-dose-expansion |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PF-07104091 + PF-07220060 + letrozole dose expansion CI brief — competitive landscape report
- PF-07104091 + PF-07220060 + letrozole dose expansion updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about PF-07104091 + PF-07220060 + letrozole dose expansion
What is PF-07104091 + PF-07220060 + letrozole dose expansion?
PF-07104091 + PF-07220060 + letrozole dose expansion (pf-07104091-pf-07220060-letrozole-dose-expansion) is a pharmaceutical drug developed by Pfizer Inc..
Who makes PF-07104091 + PF-07220060 + letrozole dose expansion?
PF-07104091 + PF-07220060 + letrozole dose expansion is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of PF-07104091 + PF-07220060 + letrozole dose expansion?
pf-07104091-pf-07220060-letrozole-dose-expansion is the generic (nonproprietary) name of PF-07104091 + PF-07220060 + letrozole dose expansion.
What development phase is PF-07104091 + PF-07220060 + letrozole dose expansion in?
PF-07104091 + PF-07220060 + letrozole dose expansion is in Phase 1.